Differences in the pathological patterns of non-specific pleuritis (NSP).
G. Karpathiou (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), C. Brun (Saint-Etienne, France), F. Forest (Saint-Etienne, France), N. Rahman (Oxford, United Kingdom), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France)
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Karpathiou (Saint-Etienne, France), S. Hathroubi (Saint-Etienne, France), A. Patoir (Saint-Etienne, France), O. Tiffet (Saint-Etienne, France), F. Casteillo (Saint-Etienne, France), C. Brun (Saint-Etienne, France), F. Forest (Saint-Etienne, France), N. Rahman (Oxford, United Kingdom), M. Peoc'H (Saint-Etienne, France), M. Froudarakis (Saint-Etienne, France). Differences in the pathological patterns of non-specific pleuritis (NSP).. 2871
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Differences and characteristics of COVID-19 and atypical pneumonia Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Clinical presentation on nonspecific (NSIP) compared to usual (UIP) interstitial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001
Differences in inflammation biomarkers among COVID-19 and Non-COVID-19 pneumonia. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Clinical significance of histological UIP pattern in interstitial pneumonia with autoimmune features (IPAF) Source: International Congress 2017 – Novel and old entities Year: 2017
CD8 BAL lymphocytosis differentiates usual interstitial pneumonia (UIP) from sarcoidosis (SA); correlation with clinical parameters Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001
Different expression profiles of gelsolin in various types of idiopathic interstitial pneumonias (IIPs). A tissue microarray study Source: Eur Respir J 2007; 30: Suppl. 51, 573s Year: 2007
Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB) Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006
Differences between age related clinical presentation of pulmonary tuberculosis (TB) Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Peripheral blood changes in usual interstitial pneumonia (UIP) and non specific interstitial pneumonia (NSIP), possible biomarkers of oxidative stress Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
Comparison of fibroblastic foci scoring systems in usual interstitial pneumonia (UIP) Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003
Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP) Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Corticosteroid (CS) therapy does not influence immune reactivity in patients with non-specific interstitial pneumonia (NSIP) Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Non-specific interstitial pneumonia (NSIP) - a study of 12 patients Source: Eur Respir J 2002; 20: Suppl. 38, 60s Year: 2002
Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
CT features of fibrosing alveolitis in rheumatoid arthritis (FARA): a comparison with idiopathic usual interstitial pneumonia (UIP) and non-specific interstitial pneumonia (NSIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts) Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010